You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(04.19)︱中國建材首季歸母淨利預增超200%;遠大醫藥創新藥比利時獲批治療新冠病毒IIa期臨牀研究
格隆匯 04-19 23:06

【財務數據】

中國鐵塔(00788.HK)一季度淨利升16.7%至16.94億元 全力聚焦"一體兩翼"戰略落地

晨鳴紙業(01812.HK)一季度淨利潤11.79億元 同比增長481.42%

【業績預吿】

中國建材(03323.HK)首季歸母淨利預增超200%

勝利證券(08540.HK)預計首季純利大增1.97倍

正大企業國際(03839.HK)首三月預盈500萬美元

順興集團控股(01637.HK)年度淨利預增不少於50%

域高金融(08340.HK)預期一季度虧損約177萬港元

暢捷通(01588.HK)預計一季度由盈轉虧3500萬至4500萬元 雲服務新增付費企業用户數增長80%

華廈置業(00278.HK)預計年度由虧轉盈300萬港元

【運營數據】

李寧(02331.HK):一季度李寧銷售點(不包括李寧YOUNG)零售流水按年錄得80%-90%高段增長

人瑞人才(06919.HK)截至3月底靈活用工人數增至3.64萬人 同比增長42.3%

中國能源建設(03996.HK)一季度新籤合同額2438.72億元 同比增長90.96%

綠色動力環保(01330.HK):一季度合計垃圾進廠量同比增長36.16%、發電量同比增長58.5%

華電國際電力股份(01071.HK):一季度發電量5990萬兆瓦時 同比增長28.67%

香港醫思醫療集團(02138.HK)預期中國內地診所及服務中心年度銷售額同比增加不少於60%

友聯租賃(01563.HK)擬收購煙台南山學院全部權益

【增減持】

中基長壽科學(00767.HK):主席閆立向主要股東收購1.84億股公司股份

鼎豐集團控股(06878.HK)獲行政總裁兼執行董事吳志忠增持1200萬股

【併購出售】

世茂服務(00873.HK)擬不超5.06億元收購深圳深兄環境67%股權

聯合醫務(00722.HK)收購東藝有限公司75%權益

協同通信(01613.HK)擬1000萬港元認購堯領3.33%股權

中國綠島科技(02023.HK)擬5655萬元收購聯營公司82%股權

壹傳媒(00282.HK)擬出售Amazing Sino International全部股權

【增發供股】

中發展控股(00475.HK)擬溢價約11.94%配發1530萬股 籌資1141萬港元

【投資運營】

遠大醫藥(00512.HK):OncoSec基因電轉設備GenPulse™獲得歐盟CE認證

遠大醫藥(00512.HK):全球創新產品STC3141在比利時獲批開展與COVID-19相關的IIa期臨牀研究

石藥集團(01093.HK):度恩西布膠囊上市申請獲國家藥監局受理

中國玻璃(03300.HK)擬成立合資 於宿遷建立光伏超白壓延玻璃生產基地

中國同輻(01763.HK):原子高科取得治療用碘化鈉膠囊藥品註冊證書

中信股份(00267.HK):中信海直與自貢人民政府簽訂戰略合作協議

東陽光藥(01558.HK):草酸艾司西酞普蘭片獲批准上市

【回購註銷】

小米集團-W(01810.HK)4月19日耗資約1.97億港元購回740萬股B類普通股

恆安國際(01044.HK)4月19日耗資2064.1萬港元回購40萬股

中國星集團(00326.HK)4月19日耗資797.5萬港元回購550萬股

皇娛樂酒店(00296.HK)4月19日耗資172萬港元回購135.5萬股

中國旺旺(00151.HK)4月19日耗資475.3萬港元回購80.9萬股

【股權激勵】

創業集團控股(02221.HK)授出4649.2萬份購股權

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account